Outsourcing-Pharma – Trials suggest long-acting antipsychotics use should be expanded
Q&A with Andreas Schreiner, M.D., Executive Director, Medical Affairs Neuroscience & Analgesia
Clinical Research: Phase 1 - Phase 4
Outsourcing-Pharma – Trials suggest long-acting antipsychotics use should be expanded
By Andreas Schreiner |December 19, 2018